Zuellig Pharma
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region.
See below for the Latest Zuellig Pharma News, Analysis, Profit Results, Share Price Information, and Commentary.
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
Most Read
1. SGH and NNI study reveals connection between scoliosis and brainstem 2. Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia 3. 3 in 5 novice nurses struggle with higher-complexity procedures 4. EGH Campus in Bedok North to offer services before 2030 completion 5. Around 4 in 5 healthcare organistation plan IT modernisationResource Center
Event News
Event News
Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi
Co-Written / Partner
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
Co-Written / Partner
Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
Videos
Partner Sites
Join the community